The Nature and Diversity of Catalytic Protein- 93 



29. L. A. Heppel, D. R. Harkness, and R. J. Hilmoe, A Study of the substrate 



specificity and other properties of the alkaline phosphatase of Escherichia coli, 

 J. Biol. Chem., 237:811-846 (1962). 



30. P. D. Boyer, R. C. Mills, and H. J. Fromm. Hypotheses for and some kinetic 

 studies with glutamine synthetase and aretate thiokinase, Arch. Biochem. Bio- 

 phys., 81:249-263 (1959). 



31. P. D. Boyer. Uses and limitations of measurements of rates of isotopic exchange 

 and incorporation in catalyzed reactions. Arch. Biochem. Biophys., 82:387-410 

 (1959). 



32. I. A. Rose. The mechanism of action of aldolase and the asymmetric labeling 

 of hexose. Proc. Nat. Acad. Sci. U.S., 44:10-15 (1958). 



33. J. M. Buchanan and S. C. Hartman, Enzymic reactions in the synthesis of the 

 purines, Advances in Enzymol.. 21 : 199—261 (1959). 



34. P. Berg, Role of magnesium in acetyl coenzyme A formation by acetothiokina-e. 

 Science, 129:895-896 (1959). 



35. H. M. Levy and D. E. Koshland. Jr.. Mechanism of hydrolysis of adenosine- 

 triphosphate by muscle proteins and its relation to muscular contraction. J. Biol. 

 Chem., 234:1102-1107 (1959). 



36. P. D. Boyer, W. W. Luchsinger, and A. B. .Falcone. 18 and P 32 exchange reac- 

 tions of mitochondria in relation to oxidative phosphorylation. J. Biol. Chem.. 

 223:405-121 (1956). 



37. M. E. Dempsey and P. D. Boyer, Catalysis of an inorganic phosphate-FLO 18 

 exchange by actomyosin and myosin. J. Biol. Chem., 236 :PC 6 (1961). 



38. M. Nozaki. T. Yamanaka. T. Horio, and K. Okuniki. Cytochrome c. I. Purifica- 

 tion procedures and proteinase digestion of bakers' yeast cytochrome c. J. Bio- 

 chem. (Tokyo), 44:453-464 (1957). 



39. A. Kowalsky. unpublished. 



40. R. D. Hotchkiss and A. H. Evans, Fine structure of a genetically modified enzyme 

 as revealed by relative affinities for modified substrate. Federation Proc. 19: 

 912-925 (1960). 



41. F. Kubowitz and P. Ott. Isolierung und Kristallisation eines Garung*fcrmentes 

 aus Tumoren. Biochem. Z., 314:94-117 ( 1943 ) . 



42. E. P. Anderson and L. W. Law. Biochemistry of cancer. Ann. Rev. Biochem.. 

 29:577-608 (1960). 



43. A. Wacker, A. Trebst, and H. Simon, Uber den stoffwechsel des Sulfanilamids- 

 S 35 bei empfindlichen und resistenten Bakterien, Z. Naturforsch., 12b: 3 15-319 

 (1957). 



44. K. Saz and L. M. Martinez, Enzymatic basis of resistance to Aureomycin. II. In- 

 hibition of electron transport in Escherichia coli by Aureomycin. J. Biol. Chem.. 

 233:1020-1022 (1958). 



45. P. Reichard, O. Skold. and G. Klein, Possible enzymic mechanism for the de- 

 velopment of resistance against fluorouracil in ascites tumors, Nature (London), 

 183:939-911 (1959). 



46. R. W. Brockman, L. L. Bennett, Jr.. M. S. Simpson. A. R. Wilson. J. R. Thomson, 

 and II. E. Skipper, A mechanism of resistance to 8-azaguanine II. Studies with 

 experimental neoplasms, Cancer Research, 19:856-869 (1959). 



47. C. Heidelberger, G. Kaldor, K. L. Mukherjee, and P. B. Dannebtrg, Studies on 

 fluorinated pyrimidines. XL In vitro studies on tumor resistance, Cancer Re- 

 search, 20:903-906 (1960). 



